Latest News

LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.

Bass Oil June output up 3% to 225 bopd as Bunian-6 starts; aims to double group output - Vanessa gas field acquired, first sales by year-end.

Coventry Group Q4 FY26: sales $98.5m, EBITDA $4.1m—second straight uplift; cash flow positive at $5.9m, $10m annualised savings fueling FY27 turnaround.

Dimerix expands kidney pipeline with DMX-652 acquisition; Phase 2-ready AKI therapy targets US$3.5b market, upfront US$5m plus up to US$292m milestones.

Iltani Resources validates ore sorting at Orient via XRT, boosting silver to 265 g/t and indium to 427 g/t; potential to cut throughput and costs.

Tartana Minerals signs two-tranche A$5.18m placement with Xingye Gold to become its largest shareholder at up to 19.99%, premium, funding exploration.

Resolution Minerals secures FAST-41 for Golden Gate, boosting US permitting, investor visibility, and NASDAQ-listing prospects as 13,700m drilling continues.

Caravel Minerals completes mining DFS for Caravel copper project, revealing 597 Mt @0.24% Cu (1.42 Mt Cu) and staged open-pit plan toward autonomous haulage.

Condor Energy completes Piedra Redonda feasibility study, confirming 1 Tcf 2C gas and two development concepts (30-150 MMscf/d) to advance sales and financing.

Altair Minerals expands Greater Oko drill program to 75,000m RC/diamond; two new RC rigs, 18-month campaign, fully funded with $38m cash.

Argenica's ARG-007 delivers durable neuroprotection after repeat mild TBI in a concussion model, hinting at a disease-modifying therapy from a single dose.

Lunnon Metals hits best month to date at Lady Herial: 62,000t ore @1.73g/t for 3,473 oz gold; St Ives deal adds $12m cash, boosting FY outlook.